Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.
The University of Washington (UW) School of Medicine will begin a complete overhaul of its electronic health record (EHR) system—and it’s not going to be cheap. The school’s finance committee approved $180 million to replace existing Cerner and Epic systems with a single integrated platform.
State officials have agreed to a $3.19 million upgrade to the MRI services offered at Northeastern Vermont Regional Hospital in St. Johnsbury, Vermont.
A confidential medical file containing the names, hometowns and histories of 26 breast cancer patients was misplaced in a south New Zealand town this week, the Otago Daily Times has reported.
The shutdown of Australia’s sole nuclear medicine generator due to mechanical problems is beginning to impact patient treatment, particularly for individuals in rural parts of the country, the Guardian reported.
Adding contrast-enhanced ultrasound (US) to traditional US could promote better, more sensitive detection and diagnosis of breast lesions, researchers reported in Clinical Radiology this July.
Commercial health plans vary widely in how they cover specialty drugs, and coverage is not typically based on available evidence-based data, according to a recent study from Tufts Medical Center researchers published online July 9 in Health Affairs.
Radiologists struggling to hone their communication skills might be helped by simulated learning and hands-on practice, according to a report published in Current Problems in Diagnostic Radiology this month.
New ultra-thin drug-eluting stents (DES) are associated with a 16 percent reduction in target lesion failure (TLF) at one year compared to thicker-strut, second-generation DES, according to a meta-analysis published June 26 in Circulation.
Patients with retrievable inferior vena cava (IVC) filters used to prevent venous thromboembolisms face increased complication risks the longer their device remains in the body. Researchers created an informatics tool to address the issue.
